India Reports First Suspected Mpox Case as Man Returning from Abroad Is Isolated

Balasahana Suresh
India Reports First Suspected Mpox Case as Man Returning from Abroad Is Isolated
A young man who recently returned from a country experiencing an Mpox (monkeypox) outbreak has been identified as a suspected case, marking India’s first such instance.
The individual, who is showing symptoms but remains stable, has had samples collected to verify the presence of the virus. Authorities have initiated contact tracing and are managing the case according to established protocols. This includes identifying potential sources and assessing the impact within the country.
This case is in line with the National Centre for Disease Control (NCDC)'s previous risk assessments. Officials have stated that there is no immediate cause for concern, emphasizing that india is well-prepared to handle isolated cases related to travel.
Stringent measures are in place to manage and mitigate any potential risk associated with the virus.
What Is Mpox and How Does It Spread? Mpox is caused by a virus transmitted from infected animals to humans, and can also spread from person to person through close physical contact. It can be severe, leading to fever, muscle aches, and large boil-like skin lesions.
The World health Organization declared an international emergency on august 14 due to a surge in cases of the Clade 1b strain in the democratic republic of congo (DRC) and its spread to neighboring countries. A vaccination campaign in Congo is scheduled to start on october 2.
The 2022 epidemic was caused by Clade 2, which continues to circulate in many countries, particularly in the West. However, the current outbreak in the DRC is attributed to the Clade 1 strain, which has become more complex with the emergence of the new variant 1b.
Initially discovered in monkeys in denmark in 1958, and first identified in humans in Zaire (now the DRC) in 1970, the Mpox virus's danger and level of contagion for the Clade 1b variant remain difficult to assess. The WHO has noted a rapid increase in cases of Clade 1b but reported relatively few deaths.



Find Out More:

Related Articles: